After researching and watching carefully for months, listening to the Elder Longs with significant positions , talking with the GMU BioDefence Dept, emailing and reading replies from LE, Reading Russian documents plus reading articles where DeGrado is using Bril to assist in his research efforts and scouring the internet regarding the mention of Brilacidin.

I have formed an Opinion which proposes a probable direction for Innovations Pharma. Namely this:
A. It is likely possible that Bril will be leased to Gilead for US sales manufacturing and distribution.
B. Takeda or Merck will take over the majority foreign Sales and distribution leaving Gilead as a sole source manufacture.
C. A buyout is very Highly unlikely.
D. Possible that Kevetrin would be tied into the Gilead deal

Bottom line: this just a logical opinion. The business competition is unpredictable.

For example offer me enough money and I will sell you everything Ive got except, Jesus, my Wife, my kids and my cat. OK maybe my kids but that’s it. RP